---
title: ARPA-H Announces New Funding Opportunity to Make AI-enabled Tools More Reliable
---

ARPA-H has launched the PRECISE-AI program to ensure AI-enabled medical tools stay accurate and reliable over time.

| View in browser Thursday, September 5, 2024 \| 2 minutes, 19 seconds, or ~139 heartbeats ARPA-H Announces New Funding Opportunity to Make AI-enabled Tools More Reliable  The Big Picture: ARPA-H has launched the PRECISE-AI (Performance and Reliability Evaluation for Continuous Modifications and Useability of Artificial Intelligence) program to ensure AI-enabled medical tools stay accurate and reliable over time. AI-enabled medical devices: From virtual assistants to enhanced medical imaging and diagnostic tools, new AI-enabled tools have transformed doctors’ ability to provide care. Why It Matters: While AI tools in health care are booming, their performance can degrade due to changes in data, operations, patient populations, or even IT infrastructure. PRECISE-AI aims to develop capabilities that automatically detect and correct these issues, ensuring tools remain effective and safe. By the numbers: Today, more than 950 medical devices with integrated AI functionalities have been authorized by the FDA—a tenfold increase from 2018 to 2023. What They’re Saying: “The inability to automatically monitor and maintain an AI-enabled medical device’s performance based on real-world operations creates risks for clinicians and patients,” said PRECISE-AI Program Manager Dr. Berkman Sahiner. “PRECISE-AI aims to create a suite of techniques that can maintain peak performance of AI-enabled tools by recommending the optimal approach to detect and mitigate the underlying AI model performance degradation so that clinicians can provide better patient care.”   What’s Next: PRECISE-AI will hold a hybrid Proposers’ Day for all interested performers this fall. Stay up to date by visiting the PRECISE-AI program page. How ARPA-H Embraces Risks to Accelerate Better Health Outcomes for Everyone  In an essay for the Milken Institute, ARPA-H Director Dr. Renee Wegrzyn explains how ARPA-H makes pivotal investments in high-risk, high-reward ideas that cannot be achieved through traditional research or investment.   “To address the biggest problems in human health today, we need to take bigger risks on bolder ideas,” she writes. “This means going beyond stepwise progress and asking ourselves 'What if?' What if we had a single at-home test that could detect multiple types of cancer? What if we could transplant an entire human eye to restore vision? What if we could bring hospital-level health care to the doorstep of isolated rural populations?”   “Imagining these new frontiers is important, but it is not enough. To translate ideas into action, we also need ways to take bigger risks, which de-risk these hoped-for solutions as they move closer to becoming reality.” Read the full essay on the Milken Institute’s website. Elsewhere in the ARPAsphere: EXPLORATION TOPICS PROVIDE UNIQUE FUNDING OPPORTUNITIES. Two unique funding opportunities are now open: 1) PRO-MICROBE ET, which funds research on an indoor environmental quality index, and 2) DECIDE-ET, which funds research to advance new quality assurance technologies and reimbursement pathways for rare disease therapies. Submit a proposal today. THIRD NITRO OA MODEL MEETING: The third NITRO Osteoarthritis Model Meeting is Sept. 17. Register today (the deadline is noon ET on Sept. 10)! REGISTER FOR UPCOMING GLIDE PROPOSERS’ DAY: Be sure to register for GLIDE’s upcoming hybrid Proposers’ Day on Oct. 1 (deadline Sept. 24) to hear more about the program from Program Manager Dr. Kimberly Steele. TWO ARPA-H PROGRAMS UP FOR INNOVATION OF THE YEAR: Both UPGRADE and PARADIGM have been nominated as Innovations of the Year by CyberScoop and Fedscoop, respectively, celebrating cutting-edge applications of tech that have distributed traditional government operations and processes for the sake of greater impact. Vote today! You received this email because you expressed an interest in ARPA-H. If you are not interested in receiving intermittent emails with ARPA-H news and events, please unsubscribe below. Connect with us.             Interested in leading biomedical research that could change the world? Learn more at arpa-h.gov. Note: HubSpot may collect geolocation data and time zone; IP address, time, and date of signup and opt-in confirmation. ARPA-H, 11601 Landsdown Street, Rockville, MD 20852, United States Unsubscribe Manage preferences Copyright © 2024 ARPA-H, All rights reserved. |
| --- |